Modified vaccinia virus Ankara as a vaccine against feline coronavirus: Immunogenicity and efficacy

Journal of Feline Medicine and Surgery

Volumn 6, Issue 2, 2004, Pages 111-118

  Hebben, Matthias ^a   Duquesne, Véronique ^a   Cronier, Joëlle ^a   Rossi, Bernard ^b   Aubert, André ^a  

^a Virbac SA   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; VACCINIA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; CAT DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CORONAVIRUS; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; VACCINATION; VIRUS STRAIN; VIRUS VECTOR;

CORONAVIRUS; FELIDAE; FELINE CORONAVIRUS; FELINE INFECTIOUS PERITONITIS VIRUS; FELIS CATUS; MURINAE; POXVIRIDAE; VACCINIA VIRUS; VECTORS;

EID: 1842633812     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2003.12.011     Document Type: Conference Paper

References (17)

1. Amara, R.R., Villinger, F., Staprans, S.I., Altman, J.D., Montefiori, D.C., Kozyr, N.L., Xu, Y., Wyatt, L.S., Earl, P.L., Herndon, J.G., McClure, H.M., Moss, B., Robinson, H.L., 2002. Different patterns of immune responses but similar control of a Simian-Human Immunodeficiency Virus 89.6P mucosal challenge by Modified Vaccinia Virus Ankara (MVA) and DNA/MVA vaccines. Journal of Virology 76(15), 7625-7631.
2. Antoine, G., Scheiflinger, F., Dorner, F., Falkner, F.G., 1998. The complete genomic sequence of the Modified Vaccinia Ankara strain: comparison with other Orthopoxviruses. Virology 244, 365-396.
3. Bronte, V., Carroll, M.W., Goletz, T.J., Wang, M., Overwijk, W.W., Marincola, F., Rosenberg, S.A., Moss, B., Restifo, N.P., 1997. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proceedings of the National Academy of Science U S A 94(7), 3183-3188.
4. Kotwal, G. J., 2000. Poxviral mimicry of complement and chemokine system components: what's the end game? Immunology Today 21(5), 242-248.
5. Okamura, H., Tsutsui, H., Kashiwamura, S., Yoshimoto, T., Nakanishi, K., 1998. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Advances in Immunology 70, 281-312.
6. Olsen, C.W., 1993. A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination. Veterinary Microbiology 36, 1-37.
7. Paoletti, E., Gettig, R., 1997. Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them. International patent, IPN: WO 97/20054.
8. Pedersen, N.C., 1987. Virologic and immunologic aspects of feline infectious peritonitis virus infection. Advances in Experimental Medical Biology 218, 529-550.
9. Pedersen, N.C., Evermann, J.F., McKeirnan, A.J., Ott, R.L., 1984. Pathogenicity studies of feline coronavirus isolates 79-1146 and 79-1683. American Journal of Veterinary Research 45(12), 2580-2585.
10. Ramirez, J.C., Gherardi, M.M., Esteban, M., 2000a. Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B-and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine. Journal of Virology 74(2), 923-933.
11. Ramirez, J.C., Gherardi, M.M., Rodriguez, D., Esteban, M., 2000b. Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector. Journal of Virology 74(16), 7651-7655.
12. Ramshaw, I.A., Ramsay, A.J., 2000. The prime-boost strategy: exciting prospects for improved vaccination. Immunology Today 21(4), 163-165.
13. Smith, V.P., Bryant, N.A., Alcami, A., 2000. Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. Journal of General Virology 81(5), 1223-1230.
14. Sutter, G., Moss, B., 1992. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proceedings of the National Academy of Science U S A 89, 10847-10851.
15. Vennema, H., de Groot, R.J., Harbour, D.A., Dalderup, M., Gruffydd-Jones, T., Horzinek, M.C., Spaan, W.J.M., 1990. Early death after feline infectious peritonitis virus challenge due to a recombinant vaccinia virus immunization. Journal of Virology 64(3), 1407-1409.
16. Vennema, H., de Groot, R.J., Harbour, D.A., Horzinek, M.C., Spaan, W.J.M., 1991. Primary structure of the membrane and nucleocapsid protein genes of feline infectious peritonitis virus and immunogenicity of recombinant vaccinia viruses in kittens. Virology 181, 327-335.
17. Wyatt, L.S., Shors, S.T., Murphy, B.R., Moss, B., 1996. Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model. Vaccine 14(15), 1451-1458.